PL114494B1 - Process for preparing novel derivatives of imidazole - Google Patents

Process for preparing novel derivatives of imidazole Download PDF

Info

Publication number
PL114494B1
PL114494B1 PL1978209693A PL20969378A PL114494B1 PL 114494 B1 PL114494 B1 PL 114494B1 PL 1978209693 A PL1978209693 A PL 1978209693A PL 20969378 A PL20969378 A PL 20969378A PL 114494 B1 PL114494 B1 PL 114494B1
Authority
PL
Poland
Prior art keywords
imidazole
naphtho
solution
methyl
group
Prior art date
Application number
PL1978209693A
Other languages
English (en)
Polish (pl)
Other versions
PL209693A1 (pl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL209693A1 publication Critical patent/PL209693A1/xx
Publication of PL114494B1 publication Critical patent/PL114494B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL1978209693A 1977-09-19 1978-09-19 Process for preparing novel derivatives of imidazole PL114494B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU78140 1977-09-19
CH814978 1978-07-28

Publications (2)

Publication Number Publication Date
PL209693A1 PL209693A1 (pl) 1979-06-04
PL114494B1 true PL114494B1 (en) 1981-01-31

Family

ID=25702876

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978209693A PL114494B1 (en) 1977-09-19 1978-09-19 Process for preparing novel derivatives of imidazole

Country Status (36)

Country Link
US (2) US4182766A (instruction)
EP (1) EP0001279B1 (instruction)
JP (1) JPS5459274A (instruction)
AR (1) AR224350A1 (instruction)
AT (1) AT368152B (instruction)
AU (1) AU519711B2 (instruction)
BG (1) BG28708A3 (instruction)
BR (1) BR7806148A (instruction)
CA (1) CA1106849A (instruction)
DD (1) DD138210A5 (instruction)
DE (2) DE2861237D1 (instruction)
DK (1) DK406578A (instruction)
EG (1) EG13530A (instruction)
ES (1) ES473451A1 (instruction)
FI (1) FI64365C (instruction)
FR (1) FR2403340A1 (instruction)
GB (1) GB2004281B (instruction)
GR (1) GR73069B (instruction)
HU (1) HU176111B (instruction)
IE (1) IE47363B1 (instruction)
IL (1) IL55557A (instruction)
IN (1) IN148930B (instruction)
IT (1) IT1098858B (instruction)
MC (1) MC1213A1 (instruction)
MT (1) MTP835B (instruction)
NL (1) NL7809529A (instruction)
NO (1) NO149962C (instruction)
NZ (1) NZ188405A (instruction)
OA (1) OA06054A (instruction)
PH (1) PH16342A (instruction)
PL (1) PL114494B1 (instruction)
PT (1) PT68573A (instruction)
RO (1) RO75258A (instruction)
SE (1) SE7809792L (instruction)
SU (1) SU793390A3 (instruction)
YU (1) YU216778A (instruction)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4368201A (en) * 1981-07-20 1983-01-11 Usv Pharmaceutical Corporation Tetrahydronaphthoxazoles
IL66340A (en) * 1981-08-13 1986-08-31 Haessle Ab Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation
HU191757B (en) * 1983-05-03 1987-04-28 Byk Gulden Lomberg Chem Fab Process for producing new tricyclic ethers
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
CA1341314C (en) * 1984-07-06 2001-11-06 David Cox Derivatives of benzimidazole, benzothiazole and benzoxazole
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
EP0204215B1 (en) 1985-05-24 1993-08-11 G.D. Searle & Co. 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
DE3701277A1 (de) * 1987-01-17 1988-07-28 Boehringer Mannheim Gmbh Neue tricyclische benzimidazole, verfahren zu ihrer herstellung und verwendung als arzneimittel
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
CA2138787A1 (en) * 1992-07-08 1994-01-20 Clifton Augustus Baile Alleviating stomach ulcers in swine
AU2395095A (en) * 1994-04-29 1995-11-29 G.D. Searle & Co. Method of using (h+/k+) atpase inhibitors as antiviral agents
HU227566B1 (en) * 1995-09-21 2011-08-29 Pharma Pass Llc Acid-labile pharmaceutical composition containing omeprazole and process for its preparation
US5840737A (en) * 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
KR100463031B1 (ko) * 1997-05-26 2005-04-06 동아제약주식회사 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6733778B1 (en) * 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
EP1603537A4 (en) * 2003-02-20 2009-11-04 Santarus Inc NOVEL FORMULATION, ANTICIPATED COMPLEX IMMEDIATE RELEASE FOR A FAST AND CONTINUOUS SUPPRESSION OF MAGIC ACID
US20050037070A1 (en) * 2003-07-18 2005-02-17 Santarus, Inc. Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI337877B (en) * 2003-07-18 2011-03-01 Santarus Inc Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
GB2444593B (en) 2006-10-05 2010-06-09 Santarus Inc Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2086543A2 (en) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
EP4598528A1 (en) 2022-10-04 2025-08-13 Arsenil Zabirnyk Inhibition of aortic valve calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985661A (en) * 1956-02-06 1961-05-23 American Cyanamid Co Preparation of 2(omicron-aminophenyl)-benzimidazole
GB1234058A (instruction) * 1968-10-21 1971-06-03
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen

Also Published As

Publication number Publication date
NO149962C (no) 1984-07-25
FI64365C (fi) 1983-11-10
US4182766A (en) 1980-01-08
EG13530A (en) 1981-12-31
DE2861237D1 (en) 1981-12-10
PL209693A1 (pl) 1979-06-04
PH16342A (en) 1983-09-05
JPS5459274A (en) 1979-05-12
SE7809792L (sv) 1979-03-20
US4248880A (en) 1981-02-03
FR2403340B1 (instruction) 1981-02-13
RO75258A (ro) 1980-11-30
OA06054A (fr) 1981-06-30
NZ188405A (en) 1981-03-16
IT1098858B (it) 1985-09-18
AU3981778A (en) 1980-03-20
EP0001279B1 (de) 1981-09-30
AR224350A1 (es) 1981-11-30
GR73069B (instruction) 1984-01-30
ES473451A1 (es) 1979-05-01
IL55557A (en) 1982-02-28
FR2403340A1 (fr) 1979-04-13
PT68573A (fr) 1978-10-01
IL55557A0 (en) 1978-12-17
IN148930B (instruction) 1981-07-25
DE2840591A1 (de) 1979-03-29
NO783155L (no) 1979-03-20
ATA673378A (de) 1982-01-15
MC1213A1 (fr) 1979-05-18
BR7806148A (pt) 1979-04-17
NO149962B (no) 1984-04-16
DD138210A5 (de) 1979-10-17
DK406578A (da) 1979-03-20
CA1106849A (en) 1981-08-11
AT368152B (de) 1982-09-27
IE781878L (en) 1979-03-19
IE47363B1 (en) 1984-03-07
FI64365B (fi) 1983-07-29
HU176111B (en) 1980-12-28
EP0001279A1 (de) 1979-04-04
MTP835B (en) 1979-11-14
BG28708A3 (bg) 1980-06-16
GB2004281B (en) 1982-03-10
GB2004281A (en) 1979-03-28
NL7809529A (nl) 1979-03-21
IT7827861A0 (it) 1978-09-19
YU216778A (en) 1983-01-21
SU793390A3 (ru) 1980-12-30
AU519711B2 (en) 1981-12-17
FI782847A7 (fi) 1979-03-20

Similar Documents

Publication Publication Date Title
PL114494B1 (en) Process for preparing novel derivatives of imidazole
EP0005129B1 (en) Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation
HU187521B (en) Process for producing new substituted benzimidazoles
PL133712B1 (en) Process for preparing novel 2-guanidine-4-heteroarylothiazoles
CH666033A5 (de) 1,4-dihydropyridinderivate und deren salze und hydrate, verfahren zur herstellung dieser verbindungen und solche verbindungen enthaltende pharmazeutische praeparate.
DE3782621T2 (de) Imidazol-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, welche diese enthalten, verwendung dieser zur herstellung therapeutisch wirksamer arzneimittel und zwischenprodukte, welche beim herstellungsverfahren entstehen.
DE2823197A1 (de) Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
PL181801B1 (pl) Podstawione aryloalkilotioalkilotiopirydyny do zwalczania bakterii Helicobacter oraz srodek leczniczy zawierajacy podstawione aryloalkilotioalkilotiopirydyny PL
EP0261478B1 (de) Neue Derivate von 4,5-Dihydro-oxazolen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19513048A1 (de) Neue 5-Pyrrolyl-6-halogen-2-pyridylmethylsulfinylbenzimidazol-Derivate
US4497810A (en) Thiatriazine dioxides as gastric anti-secretory agents
US5134151A (en) 2-picolylamine derivatives
HU194244B (en) Process for production of derivatives of new tieno /2,3-d/ imidasole and medical compounds containing thereof
US4859679A (en) Antiulcer (alkyldithio) quinoline derivatives
DE3415971A1 (de) Acylierte benzimidazole, verfahren zu ihrer herstellung, ihre anwendung und sie enthaltende arzneimittel
CS250248B2 (en) Method of imidazole's tricyclic derivatives production
PL182517B1 (pl) Tiopirydyny do zwalczania bakterii Helicobacter
DE60013607T2 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
PT96165A (pt) Processo de preparacao de derivados do imidazole e de composicoes farmaceuticas que os contem
JP2524420B2 (ja) ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤
EP0522887A1 (en) Imidazoles as ACAT- and thromboxane TxA2 inhibitors
KR810000633B1 (ko) 이미다졸 유도체의 제조방법
US4108999A (en) Thiazolo[3,4-b]isoquinoline derivatives, pharmaceutical compositions containing them and pharmaceutical methods using them
WO1993001183A1 (en) Imidazole derivative as acat inhibitor
NZ202386A (en) Substituted 2-pyridylmethyl(thio/sulphinyl)-benzimidazole derivatives and pharmaceutical compositions